531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results

European Journal of Cancer ◽

10.1016/s0959-8049(16)30332-x ◽

2015 ◽

Vol 51 ◽

pp. S114 ◽

Cited By ~ 3

Author(s):

D. Migliorini ◽

R. Vernet ◽

M.C. Belkouch ◽

P. Luy ◽

S. Blaser ◽

...

Keyword(s):

Clinical Trial ◽

Clinical Outcome ◽

Phase I ◽

Tumor Cells ◽

Phase I Clinical Trial ◽

Autologous Tumor ◽

Cell Technology

Download Full-text

A Phase I Clinical Trial of Lethally Irradiated Allogeneic Pancreatic Tumor Cells Transfected with the GM-CSF Gene for the Treatment of Pancreatic Adenocarcinoma. The Johns Hopkins Oncology Center, Baltimore, Maryland

Human Gene Therapy ◽

10.1089/hum.1998.9.13-1951 ◽

1998 ◽

Vol 9 (13) ◽

pp. 1951-1971 ◽

Cited By ~ 58

Author(s):

Elizabeth M. Jaffee ◽

Ross Abrams ◽

John Cameron ◽

Ross Donehower ◽

Mary Duerr ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Tumor Cells ◽

Pancreatic Adenocarcinoma ◽

Pancreatic Tumor ◽

Phase I Clinical Trial ◽

Gm Csf ◽

Oncology Center ◽

Johns Hopkins Oncology

Download Full-text

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Oncotarget ◽

10.18632/oncotarget.5463 ◽

2015 ◽

Vol 6 (38) ◽

pp. 41339-41349 ◽

Cited By ~ 30

Author(s):

Shan-Shan Jiang ◽

Yan Tang ◽

Yao-Jun Zhang ◽

De-Sheng Weng ◽

Zhong-Guo Zhou ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Tumor Infiltrating Lymphocytes ◽

Phase I Clinical Trial ◽

Primary Hepatocellular Carcinoma ◽

Autologous Tumor ◽

Infiltrating Lymphocytes

Download Full-text

352PD A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma

Annals of Oncology ◽

10.1093/annonc/mdv528.09 ◽

2015 ◽

Vol 26 ◽

pp. ix103 ◽

Cited By ~ 1

Author(s):

S. Jiang ◽

J. Xia

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Tumor Infiltrating Lymphocytes ◽

Phase I Clinical Trial ◽

Primary Hepatocellular Carcinoma ◽

Autologous Tumor ◽

Infiltrating Lymphocytes

Download Full-text

Phase I Clinical Trial of a Genetically Modified and Oncolytic Vaccinia Virus GL-ONC1 in patients with peritoneal carcinomatosis

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1324086 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

UM Lauer ◽

M Zimmermann ◽

U Koppenhöfer ◽

M Bitzer ◽

NP Malek ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Vaccinia Virus ◽

Peritoneal Carcinomatosis ◽

Genetically Modified ◽

Phase I Clinical Trial

Download Full-text

SAFETY OF A NEW CUBAN PNEUMOCOCCAL CONJUGATE VACCINE: A PHASE I CLINICAL TRIAL IN INFANTS 7 MONTH-OLD

10.26226/morressier.5731f0d7d462b8029237fd99 ◽

2016 ◽

Author(s):

Rinaldo Puga-Gomez

Keyword(s):

Clinical Trial ◽

Phase I ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Phase I Clinical Trial

Download Full-text

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.793494158 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718026292.793481389 ◽

2013 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Trial ◽

Phase I ◽

Recurrent Ovarian Cancer ◽

Phase I Clinical Trial ◽

Conditionally Replicative Adenovirus

Download Full-text

Faculty Opinions recommendation of GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726394953.793529283 ◽

2017 ◽

Author(s):

Lucy Dorrell

Keyword(s):

Clinical Trial ◽

Human Papillomavirus ◽

Phase I ◽

Therapeutic Vaccine ◽

Phase I Clinical Trial ◽

Cervical Cytology ◽

Human Papillomavirus 16 ◽

Normal Cervical Cytology

Download Full-text

Faculty Opinions recommendation of Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.736011651.793576740 ◽

2020 ◽

Author(s):

Roger Barker

Keyword(s):

Clinical Trial ◽

Phase I ◽

Phase I Clinical Trial

Download Full-text

Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.474 ◽

2021 ◽

Vol 32 (1) ◽

pp. 120-121

Author(s):

S. Hiltbrunner ◽

C. Britschgi ◽

P. Schuberth ◽

L. Bankel ◽

T.D.L. Nguyen-Kim ◽

...

Keyword(s):

Clinical Trial ◽

T Cells ◽

Phase I ◽

Local Delivery ◽

Fibroblast Activation Protein ◽

Phase I Clinical Trial ◽

Pleural Mesothelioma ◽

First Report ◽

Car T Cells ◽

Car T

Download Full-text